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Abstract
Purpose Klinefelter syndrome (KS) (47, XXY) is the
most common sex chromosome abnormality in humans.
KS is characterized by gynecomastia, tall stature, small
testes, low testosterone levels, learning disabilities, and
behavioral problems. KS is also associated with infertility
due to non-obstructive azoospermia (NOA). The mecha-
nism underlying NOA is still poorly understood, and
although there is no current treatment, the use of
microdissection testicular sperm extraction (micro-TESE)
followed by in vitro fertilization can result in successful
conception. The generation of induced pluripotent stem
(iPS) cells derived from KS patients may be useful for
studying the disease mechanism and identifying novel
therapies.
Methods Cells from a KS patient were transduced with
Sendai viral vectors encoding four transcription factors,
OCT4, SOX2, KLF4, and C-MYC, and the transduced cells
were analyzed for in vitro and in vivo pluripotency.
Results KS patient-derived iPS cells were successfully
generated and shown to produce teratomas in the testes of
SCID mice. In vitro differentiation of the iPS cells into
cardiomyocyte-like cells was confirmed by the presence of
clusters of beating cells.
Conclusions KS patient-derived iPS cells that could dif-
ferentiate into cardiomyocyte-like cells were established.
Keywords Cardiomyocyte  iPS  Klinefelter syndrome 
Stem cells  Testis
Introduction
Klinefelter syndrome (KS), or 47, XXY syndrome, is the
most common sex chromosome abnormality found in
humans, occurring in approximately 1 in 500–1000 live
deliveries [1]. KS is characterized by gynecomastia, tall
stature, small testes, low testosterone levels, learning dis-
abilities, and behavioral problems. Affected men suffer
from KS-associated progressive testicular failure (resulting
in azoospermia or cryptozoospermia), small testes
(5–7 cm3), and low testosterone levels. In addition, indi-
viduals with KS have an increased risk for various dis-
eases, including diabetes, cardiovascular disease, and
cancer, and their offspring have an increased risk for
chromosomal abnormalities [1]. Thus, it is recommended
that individuals with KS symptoms undergo prompt
cytogenic evaluation.
The KS karyotype arises spontaneously when paired X
chromosomes fail to separate during the meiosis stage of
oogenesis or spermatogenesis [2]. In addition, a small
percentage (\3 %) of X chromosome polysomy occurs
during early divisions of the fertilized egg, while more than
10 % occurs as a result of postfertilization nondisjunction
[3]. It is predicted that the aberrant expression of X chro-
mosome-linked genes plays a role in the spermatogenesis
defect seen in KS patients. However, the mechanism
underlying the infertility of KS is still poorly understood,
and the only treatment for the infertility is microdissection
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testicular sperm extraction (micro-TESE), which can result
in successful in vitro fertilization.
The development of induced pluripotent stem (iPS)
cells holds much promise for regenerative medicine.
Two seminal studies showed that human somatic cells
can be reprogrammed into pluripotent stem cells by
introducing a set of transcription factors that regulate
pluripotency [4, 5]. iPS cells possess a nearly unlimited
capacity for self-renewal and pluripotency, similar to
embryo-derived embryonic stem (ES) cells. In addition,
iPS cells are associated with fewer ethical concerns
than ES cells. The iPS cells derived from KS patients
may be useful for studying the pathogenic mechanisms
of the disease.
We previously obtained iPS cells derived from a KS
patient using the lentiviral system [6]; however, the dif-
ferentiation of these cells into neurons or cardiomyocytes
was unsuccessful. In the current study, we used a Sendai
virus vector, which expressed four transcription factors
(OCT4, SOX2, KLF4, and C-MYC), to generate iPS cells
derived from the testicular tissue of a patient with KS. We
confirmed the multipotency of the resulting iPS cells by




Written informed consent was obtained from a KS patient
who visited the Reproduction Center of Toho Medical
Center, Omori Hospital, and this study was approved by
the Ethics Committee of Toho University School of Med-
icine (24056-18016 revision). Testicular tissue of the KS
patient was obtained by micro-TESE. We analyzed the
tissue for the presence of sperm cells, but could not confirm
their presence.
Human KS testis tissue
KS testicular tissue was composed of the rete testis, Sertoli
cells, Leydig cells, and fibroblasts. The fresh tissue was
subjected to enzymatic digestion [7], and the dissociated
cells were then plated on 10-cm tissue culture dishes coated
with 0.1 % gelatin (Sigma) in a standard culture medium
[Dulbecco’s modified Eagle’s medium (DMEM, Invitro-
gen) containing 7 % fetal bovine serum (FBS), 2 mM
glutamine (Sigma), and antibiotics (50 U/ml penicillin and
50 lg/ml streptomycin, Sigma)]. These cells were incu-
bated at 37 C in a humidified atmosphere containing 5 %
CO2 for 14 days, resulting in the establishment of a KS
testicular fibroblast line.
Cell culture
Mitomycin C-treated mouse embryonic fibroblast (MEF)
feeder cells were purchased (ReproCELL) and plated in
0.1 % gelatin-coated 10-cm culture dishes in the standard
culture medium. iPS cells were generated as described
below and maintained in Primate ES medium (Re-
proCELL), supplemented with 4 ng/ml recombinant
human basic fibroblast growth factor (bFGF) (R&D Sys-
tems). The iPS cells were grown in Primate ES cell med-
ium supplemented with 4 ng/ml bFGF and 10 lM Y27632
(Wako), and the medium was changed every day. For
passaging, the iPS cells were rinsed once with Hank’s
balanced salt solution (HBSS) (Invitrogen) and incubated
in dissociation medium (ReproCELL) at 37 C. All cul-
tures were maintained at 37 C in a humidified atmosphere
containing 5 % CO2.
iPS cell generation
To generate iPS cells, CytoTuneR-iPS 2.0, a kit containing
four Sendai viruses (SeV), encoding OCT4, SOX2, KLF4,
and C-MYC (DNAVEC) was used. The KS testicular
fibroblasts were incubated in SeV-containing medium for
24 h, followed by incubation with standard medium, which
was replaced every day. Seven days later, the cells were
harvested by trypsinization, and 5 9 104 cells were placed
on MEF feeder cells in a 10-cm dish in Primate ES cell
medium supplemented with 4 ng/ml bFGF. The medium
was changed every day, and the cells were monitored daily
for morphological changes.
Reverse-transcription (RT)-PCR
Total RNA was prepared using the PureLink Micro-to Midi
Total RNA Purification System (Invitrogen). RT-PCR was
performed using the SuperScript III One-Step RT-PCR
System with PlatinumR Taq DNA Polymerase (Invitrogen)
to analyze the expression of pluripotency markers. The
following conditions were used: 55 C for 30 min for
reverse transcription, 94 C for 2 min to inactivate the
reverse transcriptase and activate the polymerase, 40 cycles
at 94 C for 15 s, 55 C for 30 s, 68 C for 1 min, and
68 C for 5 min for the final extension. The following
products were analyzed: OCT4 (315 bp), NANOG
(285 bp), and GAPDH (513 bp). The primers were as fol-
lows: OCT4, 50-GAA GGT ATT CAG CCA AAC GAC-30
(forward) and 50-GTT ACA GAA CCA CAC TCG GA-30
(reverse); NANOG, 50-TGC AAA TGT CTT CTG CTG
AGA T-30 (forward) and 50-GTT CAG GAT GTT GGA
GAG TTC-30 (reverse); GAPDH, 50-GTC CAT GCC ATC
ACT GCC A-30 (forward) and 50-TTA CTC CTT GGA
GGC CAT G-30 (reverse) [8, 9].
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Fig. 1 Generation of iPS cells
derived from the testicular
tissue of a KS patient. The
isolated cells were transduced
with an SeV construct
expressing four transcription
factors (OCT4, SOX2, KLF4,
and C-MYC). a Overview of the
KS patient. b G-banding
chromosome analysis of the KS
patient. c Morphology of the KS
patient-derived iPS cells.
Bars = 60 lm. d RT-PCR
analysis of OCT4, NANOG, and
GAPDH mRNA expression in
the iPS cells. GAPDH mRNA
was used as a loading control




To analyze the expression of stem cell markers, the Human
Embryonic Stem Cell Marker Antibody Panel was used
(R&D Systems). The cells were washed twice with phos-
phate-buffered saline (PBS), fixed with 4 % (w/v)
paraformaldehyde for 20 min, permeabilized for 60 min
with PBS containing 0.1 % (v/v) Triton X-100, and then
blocked for 3 h with PBS containing 20 % donkey serum.
The fixed samples were incubated with anti-human alkaline
phosphatase monoclonal, anti-human NANOG polyclonal,
anti-human OCT4 polyclonal, anti-human SSEA-1 mono-
clonal, and anti-human SSEA-4 monoclonal antibodies (all
from R&D Systems) as indicated, and then washed three
times with PBS containing 0.1 % (v/v) Triton X-100, and
probed with the appropriate secondary antibodies (Alexa
488-conjugated anti-goat IgG antibody or Alexa 488-con-
jugated anti-mouse IgG antibody) (Molecular Probes).
Nucleic acids were stained with SYTOXR orange nucleic
acid stain (Molecular Probes).
In vitro pluripotency assessment
Confluent iPS cells in a 6-cm dish were harvested by
trypsinization and transferred to Poly (hydroxyethyl
methacrylate-co-methyl methacrylate; HEMA-MMA)-
coated six-well dishes in primate ES cell medium without
bFGF. The medium was changed every other day, and the
cells were maintained in floating culture for 8 days. The
cells were then placed on 0.1 % gelatin-coated six-well
dishes and incubated with ES medium for 8 days. After
embryoid body formation, we confirmed the cells’ ability
to differentiate in vitro by examining the expression of
differentiation markers by immunocytochemistry. The cells
were washed twice with PBS, fixed with 4 % (w/v)
paraformaldehyde for 20 min, permeabilized for 60 min
with PBS containing 0.1 % (v/v) Triton X-100, and then
blocked for 3 h with PBS containing 20 % donkey serum.
Anti-a-fetoprotein mouse IgG (R&D Systems), anti-a-
smooth muscle actin mouse IgG (Dako), and anti-bIII-
tubulin mouse IgG (Chemicon) were used to analyze the
expression of endodermal, mesodermal, and ectodermal
markers, respectively. The cells were then washed three
times with PBS containing 0.1 % (v/v) Triton X-100, fol-
lowed by incubation with an Alexa 488-conjugated anti-
mouse IgG antibody (Molecular Probes). Nucleic acids
were stained with SYTOXR orange nucleic acid stain
(Molecular Probes).
In vivo pluripotency assessment
Approval was obtained from the Animal Committee of
Toho University School of Medicine. The registration
certificate number is ‘‘14-53-186.’’ Confluent iPS cells in a
6-cm dish were harvested by trypsinization, collected in
tubes and centrifuged, and the pellets were suspended in ES
medium supplemented with 10 lm Y27632. The cells were
then injected into the testes of 8-week-old SCID mice
(Charles River). Three months after injection, the mice
were examined for teratoma formation. The identified
tumors were dissected and fixed with 10 % formalin.
Pathological analyses were performed by the Tokyo Cen-
tral Pathology Laboratory, Japan.
Cardiomyocyte-like cell differentiation of the KS
patient-derived iPS cells
To induce the KS iPS cells to differentiate into car-
diomyocyte-like cells, we used PSdif-CardioR (StemRD).
Briefly, KS iPS cells were cultured under feeder-free
conditions on thin layer Matrigel-coated plates (BD Bio-
sciences). The cells were incubated successively in PSdif-
CardioR A, B, and C media (according to the manufac-
turer’s instructions) to induce cardiogenesis. Clusters of
beating cells typically appeared approximately 14 days
after induction.
Results
Generation of iPS cells derived from the testicular
tissue of a patient with KS
Testicular tissue was obtained from a patient with KS by
micro-TESE (Fig. 1a). G banding of the patient’s chro-
mosomes indicated the presence of an extra X chromo-
some (47, XXY) (Fig. 1b). The tissue was processed and
the isolated cells were cultured and subjected to iPS
induction by transduction with a set of SeV constructs
(see ‘‘Materials and methods’’). Cells with an ES cell-like
morphology were first visible 15–16 days after transduc-
tion. The resulting colonies were maintained under human
ES cell culture conditions (Fig. 1c). In this experiment,
we obtained approximately 20 ES cell-like colonies from
5 9 104 cells (data not shown). The colonies were col-
lected 21–25 days after transduction and transferred into a
24-well plate with MEF feeder cells in Primate ES cell
medium containing bFGF and Y27632. The morphology
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of the KS-derived cells was similar to that of human ES
cells. We confirmed that these colonies were 47, XXY by
G-banding (data not shown). From these colonies, which
represented multiple sub-cloned cell lines from the
patient, we selected one cell line for further
characterization.
KS-derived iPS cells express stem cell markers
We confirmed that the ES-like cells derived from the KS
patient expressed the undifferentiated ES cell markers
OCT4 and NANOG (Fig. 1d). In addition, we showed that
the ES-like cells did not express the exogenous transgenes
fetoprotein Nucleic acid
smooth muscle actin Nucleic acid
III tubulin Nucleic acid
a
b
Fig. 3 Embryoid body
formation and in vitro
differentiation of the KS-
derived iPS cells. a Embryoid
bodies derived from the iPS
cells in vitro. Bars = 30 lm.
b Immunostaining analysis of
the embryoid bodies and
depiction of the three germ
layers. Nuclei were stained with
SYTOXR Orange.
Bars = 100 lm
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(OCT4, SOX2, KLF4, and C-MYC) or genes encoded by the
SeV genome (data not shown). We also performed
immunocytochemistry to examine the protein expression of
ES cell markers in the iPS cells. We showed that these cells
expressed alkaline phosphatase (AP), NANOG, OCT4, and
SSEA-4, but not SSEA-1 (Fig. 2).
KS-derived iPS cells are multipotent in vitro
To investigate the multipotency of the KS-derived iPS
cells, we examined their ability to form embryoid bodies
in vitro. After culturing the cells for 8 days under floating
culture conditions, the presence of embryoid bodies was
confirmed (Fig. 3a). To examine the expression of markers
for the three germ layers, we analyzed the plate-attached
embryoid bodies by immunocytochemistry. We confirmed
that the embryoid bodies expressed a-smooth muscle actin,
a-fetoprotein, and b III-tubulin (Fig. 3b).
KS-derived iPS cells are multipotent in vivo
To examine the differentiation potential of the iPS cells
in vivo, we transplanted the cells into the testes of SCID
mice. We monitored the formation of tumors in the testes
for 3 months after the injection and confirmed the presence
of tumors during this time period (Fig. 4a). Histological
analysis of the tumors showed that the KS-derived iPS cells
were capable of differentiating into the three germ layers
in vivo (Fig. 4b).
Cardiomyocyte-like cell differentiation of iPS cells
derived from KS
To examine the ability of the KS-derived iPS cells to dif-
ferentiate into structurally and functionally mature cell
types, we cultured the cells under cardiomyocyte-like cell-





Fig. 4 Teratoma formation
after transplantation of the KS-
derived iPS cells into the testes
of SCID mice. a Teratoma
formation. b Hematoxylin and
eosin staining of sections of the
KS-derived teratomas
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confirmed the presence of clusters of beating cells (Sup-
plementary data).
Discussion
Male infertility is regarded as a major public health concern
because it affects 15 % of couples worldwide. More than
half of all infertility cases are associated with male factor
infertility [10]. In addition, approximately 15 % of idio-
pathic male factor infertility is due to azoospermia [11].
Patients with KS [1, 12–14] present with low serum
testosterone, high luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) levels, and often elevated
estradiol levels. Almost all KS patients exhibit azoosper-
mia, and few sperm cells are isolated when these patients
undergo micro-TESE. In addition, KS patients have an
increased risk of developing diseases such as diabetes,
cardiovascular disease, and cancer, and there is an increased
risk for chromosomal abnormalities in their offspring [1].
A better understanding of the mechanism(s) underlying
KS will facilitate the development of novel treatment
options for patients with this condition. Here we developed
KS-derived iPS cells, which could be useful for mecha-
nistic studies of KS. We previously generated iPS cells
derived from adult human testicular tissue using lentiviral
vectors expressing OCT4, SOX2, KLF4, and C-MYC [15].
We also succeeded in generating iPS cells derived from the
testicular tissue of a KS patient using the same system [6].
In addition, another group generated iPS cells derived from
a KS patient using retroviral vectors [16]. However, several
characteristics of Lentivirus limit its use for generating iPS
cells. For example, Lentivirus infects dividing as well as
non-dividing cells, and integrates into the host genome,
resulting in strong transgene expression. In addition, Len-
tiviral gene expression is resistant to silencing. Thus, the
genomic integration of C-MYC has the potential to increase
the tumorigenicity of the iPS cells. To generate higher
quality iPS cells, here we used the Sendai virus (SeV)
system. SeV is a negative sense, single-stranded RNA
virus, which replicates in the cytoplasm without integrating
into the host genome, and induces iPS cells efficiently.
In addition to reducing the potential tumorigenicity of
the iPS cells, various issues regarding the use of iPS cells
still need to be addressed. Recent studies have shown that
human somatic cells and iPS cells accumulate both epi-
genetic modifications and genetic mutations that affect
their properties and could impact their research utility and
clinical safety [17–19], and one study showed that iPS cell
lines exhibit epigenetic variations and broad pluripotency
[20]. Thus, extensive genetic screening and characteriza-
tion of the iPS cells is required before using them in
research or clinical studies.
Thus, among our evaluations of the KS patient-derived
iPS cells, we tested their ability to undergo cardiomyocyte-
like cell differentiation in vitro. Our finding that these cells
could differentiate into cardiomyocyte-like cells was a
strong indication of their potential for pluripotency. In
addition, we showed that these cells were capable of
undergoing embryoid formation in vitro and of forming
tumors in vivo, containing the three germ layers. Taken
together, these findings suggested that our KS-derived iPS
cells were high-quality pluripotent iPS cells.
Many researchers previously reported that both human
ES cells and iPS cells can undergo germ cell differentiation
in vitro [21–26]. It was also recently reported that the
transplantation of normal and azoospermic factor (AZF)-
deficient iPS cells into the murine seminiferous tubule
results in the formation of germ-cell-like cells, whereas iPS
cells outside the tubule fail to differentiate into germ-cell-
like cells [27]. In addition, the AZF-deficient iPS cells form
fewer primordial germ-cell-like cells, which exhibit
defective gene expression. Thus, the murine seminiferous
tubules can direct the formation and maintenance of germ-
cell-like cells from human iPS cells.
Future studies, such as those evaluating the ability of KS
patient-derived iPS cells to undergo germ cell differentia-
tion when transplanted into mice, will be required to fur-
ther characterize these cells for their utility in mechanistic
studies and potential therapeutic use.
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